Holen Sie sich die Stockscreener-App
101.52
3.33%
-3.6644
Schlusskurs vom Vortag:
$105.18
Offen:
$104.58
24-Stunden-Volumen:
415.33K
Relative Volume:
0.64
Marktkapitalisierung:
$6.77B
Einnahmen:
$136.86M
Nettoeinkommen (Verlust:
$-168.69M
KGV:
-36.13
EPS:
-2.81
Netto-Cashflow:
$-113.49M
1W Leistung:
+0.29%
1M Leistung:
+1.38%
6M Leistung:
+52.40%
1J Leistung:
+77.11%
1-Tages-Spanne:
$101.37
$105.72
1-Wochen-Bereich:
$101.22
$107.57
52-Wochen-Spanne:
$45.91
$116.00
Rhythm Pharmaceuticals Inc Stock (RYTM) Company Profile
Firmenname
Rhythm Pharmaceuticals Inc
Sektor
Branche
Telefon
857-264-4280
Adresse
222 BERKELEY STREET, BOSTON, MA
Vergleichen Sie RYTM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RYTM
Rhythm Pharmaceuticals Inc
|
101.47 | 7.02B | 136.86M | -168.69M | -113.49M | -2.81 |
|
VRTX
Vertex Pharmaceuticals Inc
|
437.92 | 112.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
699.15 | 73.91B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
418.13 | 56.81B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
893.47 | 55.46B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
193.88 | 41.92B | 447.02M | -1.18B | -906.14M | -6.1812 |
Rhythm Pharmaceuticals Inc Stock (RYTM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-25 | Eingeleitet | Citigroup | Buy |
| 2025-11-05 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2025-07-10 | Eingeleitet | Goldman | Buy |
| 2025-07-07 | Eingeleitet | Leerink Partners | Outperform |
| 2025-04-07 | Hochstufung | BofA Securities | Neutral → Buy |
| 2025-03-05 | Fortgesetzt | Stifel | Buy |
| 2025-01-02 | Eingeleitet | Jefferies | Buy |
| 2024-12-20 | Eingeleitet | Oppenheimer | Outperform |
| 2024-10-21 | Eingeleitet | Guggenheim | Buy |
| 2024-09-18 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-09-17 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2024-05-08 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-12-19 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2023-08-01 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-01-18 | Fortgesetzt | Canaccord Genuity | Buy |
| 2022-08-08 | Hochstufung | Goldman | Neutral → Buy |
| 2022-08-05 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-06-17 | Bestätigt | Needham | Buy |
| 2022-03-02 | Fortgesetzt | Stifel | Buy |
| 2022-02-17 | Hochstufung | Ladenburg Thalmann | Neutral → Buy |
| 2021-12-08 | Eingeleitet | Wells Fargo | Overweight |
| 2021-11-19 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-09-14 | Fortgesetzt | Goldman | Neutral |
| 2021-08-04 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2021-08-04 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
| 2020-11-30 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-01-08 | Eingeleitet | Goldman | Sell |
| 2019-07-12 | Hochstufung | Stifel | Hold → Buy |
| 2019-07-08 | Eingeleitet | Canaccord Genuity | Buy |
| 2019-03-13 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2018-09-07 | Fortgesetzt | Morgan Stanley | Overweight |
| 2018-06-25 | Bestätigt | Needham | Buy |
| 2018-06-15 | Bestätigt | Needham | Buy |
| 2017-10-30 | Eingeleitet | BofA/Merrill | Buy |
| 2017-10-30 | Eingeleitet | Needham | Buy |
Alle ansehen
Rhythm Pharmaceuticals Inc Aktie (RYTM) Neueste Nachrichten
Rhythm Pharmaceuticals, Inc. $RYTM Shares Sold by Marshall Wace LLP - MarketBeat
Norges Bank Invests $13.11 Million in Rhythm Pharmaceuticals, Inc. $RYTM - MarketBeat
Can Rhythm Pharmaceuticals Stock Hold Up When Markets Turn? - Trefis
Hood River Capital Management LLC Cuts Stock Holdings in Rhythm Pharmaceuticals, Inc. $RYTM - MarketBeat
New York State Common Retirement Fund Grows Stock Holdings in Rhythm Pharmaceuticals, Inc. $RYTM - MarketBeat
Rhythm Pharmaceuticals initiated with Buy at Citi on Imcivree's potential - MSN
Will Rhythm Pharmaceuticals Inc. stock gain from government policiesMarket Weekly Review & Low Risk Growth Stock Ideas - Newser
Will Rhythm Pharmaceuticals Inc. (1RV) stock beat growth indexesQuarterly Trade Summary & Free Verified High Yield Trade Plans - Newser
Rhythm Pharmaceuticals, Inc. (RYTM) Discusses FDA Extension of PDUFA Goal Date for Setmelanotide in Hypothalamic ObesitySlideshow (NASDAQ:RYTM) 2025-12-05 - Seeking Alpha
How Rhythm Pharmaceuticals Inc. (1RV) stock responds to bond marketJuly 2025 EndofMonth & Capital Protection Trading Alerts - Newser
Panagora Asset Management Inc. Has $7.55 Million Stock Position in Rhythm Pharmaceuticals, Inc. $RYTM - MarketBeat
Rhythm Pharmaceuticals, Inc. $RYTM Shares Acquired by Russell Investments Group Ltd. - MarketBeat
Is Rhythm Pharmaceuticals Inc. stock trading near support levelsMarket Risk Analysis & Reliable Price Action Trade Plans - Newser
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Will Rhythm Pharmaceuticals Inc. (1RV) stock profit from automation waveMarket Sentiment Report & Low Risk Profit Maximizing Plans - Newser
Is Rhythm Pharmaceuticals Inc. (1RV) stock at risk of policy regulationQuarterly Trade Summary & Long-Term Capital Growth Strategies - Newser
Is Rhythm Pharmaceuticals Inc. (1RV) stock expanding market penetration2025 Top Decliners & Short-Term Swing Trade Alerts - Newser
JPMorgan Chase & Co. Acquires 639,919 Shares of Rhythm Pharmaceuticals, Inc. $RYTM - MarketBeat
Citigroup Initiates Coverage of Rhythm Pharmaceuticals (RYTM) with Buy Recommendation - MSN
How Is The Market Feeling About Rhythm Pharmaceuticals Inc? - Benzinga
Rhythm Pharmaceuticals, Inc. $RYTM Shares Sold by Loomis Sayles & Co. L P - MarketBeat
Rhythm Pharmaceuticals, Inc. $RYTM Shares Purchased by Creative Planning - MarketBeat
Avoiding Lag: Real-Time Signals in (RYTM) Movement - news.stocktradersdaily.com
SG Americas Securities LLC Has $391,000 Stock Holdings in Rhythm Pharmaceuticals, Inc. $RYTM - MarketBeat
Franklin Resources Inc. Has $34.36 Million Stake in Rhythm Pharmaceuticals, Inc. $RYTM - MarketBeat
Rhythm Pharmaceuticals (NASDAQ:RYTM) Earns Buy Rating from Analysts at Citigroup - MarketBeat
How institutional buying supports Rhythm Pharmaceuticals Inc. stock2025 Buyback Activity & Precise Trade Entry Recommendations - BỘ NỘI VỤ
Rhythm: Maintaining Strong Buy On Acquired Hypothalamic Obesity Drug Progress (RYTM) - Seeking Alpha
Citigroup Initiates Coverage on Rhythm Pharmaceuticals (RYTM) wi - GuruFocus
Citigroup Initiates Rhythm Pharmaceuticals at Buy With $136 Price Target - marketscreener.com
Rhythm Pharmaceuticals Executive Sells Shares - TradingView
[Form 4] RHYTHM PHARMACEUTICALS, INC. Insider Trading Activity - Stock Titan
Rhythm Pharmaceuticals Inc. (RYTM) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Will Rhythm Pharmaceuticals Inc. (1RV) stock enhance shareholder valueOil Prices & Fast Exit/Entry Strategy Plans - newser.com
Can Rhythm Pharmaceuticals Inc. stock rebound after recent weakness2025 Big Picture & High Conviction Buy Zone Picks - newser.com
Officer Cramer Files To Sell 3,350 Of Rhythm Pharmaceuticals Inc [RYTM] - TradingView
Why analysts recommend Rhythm Pharmaceuticals Inc. (1RV) stock2025 Performance Recap & Real-Time Buy Signal Notifications - newser.com
Rhythm Pharmaceuticals Ranked 31st on Deloitte Fast 500 List - citybiz
Primecap Management Co. CA Sells 909,285 Shares of Rhythm Pharmaceuticals, Inc. $RYTM - MarketBeat
Why Rhythm Pharmaceuticals Inc. (1RV) stock is favored by hedge fundsSwing Trade & Weekly Top Performers Watchlists - newser.com
Can Rhythm Pharmaceuticals Inc. stock weather global recessionEarnings Growth Report & High Accuracy Swing Trade Signals - newser.com
Is it time to cut losses on Rhythm Pharmaceuticals Inc.Layoff News & Long-Term Growth Stock Strategies - newser.com
Finanzdaten der Rhythm Pharmaceuticals Inc-Aktie (RYTM)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):